Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flunitrazepam: more than a date rape drug.

V I Rickert1, C M Wiemann, A B Berenson

  • 1Department of Obstetrics & Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA. vaughn_rickert@smtplink.mssm.edu

Journal of Pediatric and Adolescent Gynecology
|April 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlates of HPV knowledge among low-income minority mothers with a child 9-17 years of age.

Journal of pediatric and adolescent gynecology·2014
Same author

Racial differences in the association between body fat distribution and lipid profiles among reproductive-age women.

Diabetes & metabolism·2010
Same author

Morbidity in a population of low-income, female users of MDMA and other drugs.

Substance use & misuse·2009
Same author

Racial difference in the correlates of bone mineral content/density and age at peak among reproductive-aged women.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2009
Same author

New sexual partners and readiness to seek screening for chlamydia and gonorrhoea: predictors among minority young women.

Sexually transmitted infections·2006
Same author

A profile of adolescent females with a history of sexual assault in texas: familial environment, risk behaviors, and health status.

Journal of pediatric and adolescent gynecology·2003
Same journal

A Novel TP63 Mutation in a Patient with Premature Ovarian Insufficiency Type 21: Clinical Phenotype and Diagnostic Challenges.

Journal of pediatric and adolescent gynecology·2026
Same journal

From PCOS to Polyendocrine Metabolic Ovarian Syndrome (PMOS): Implications for Adolescent Gynecologic Care.

Journal of pediatric and adolescent gynecology·2026
Same journal

GLP-1 Receptor Agonists in Adolescents: Emerging Endocrine, Reproductive, and Psychosocial Concerns.

Journal of pediatric and adolescent gynecology·2026
Same journal

Breaking Barriers: Assessing the Educational and Reproductive Health Implications of Period Poverty Among Secondary School Girls.

Journal of pediatric and adolescent gynecology·2026
Same journal

Transcutaneous Tibial Nerve Stimulation for Adolescent Dysmenorrhea: Beyond the Sham-Methodological and Mechanistic Considerations.

Journal of pediatric and adolescent gynecology·2026
Same journal

Clinical Spectrum, Morphometrics, and Management of Perineal Cleft in Female Children.

Journal of pediatric and adolescent gynecology·2026
See all related articles

Young women with severe depression and low self-esteem are at higher risk for future flunitrazepam use. Limited drug resistance self-efficacy also predicts increased likelihood of using this drug.

Area of Science:

  • Psychology
  • Psychiatry
  • Public Health

Background:

  • Flunitrazepam (Rohypnol) is a benzodiazepine with a high potential for misuse.
  • Understanding predictors of flunitrazepam use is crucial for prevention efforts, particularly among vulnerable populations.

Purpose of the Study:

  • To examine the relationship between depressive symptoms, self-esteem, drug resistance self-efficacy, and future intentions to use flunitrazepam.
  • To identify psychological factors associated with potential flunitrazepam misuse.

Main Methods:

  • A cross-sectional survey was conducted with 865 sexually active women from community-based family planning clinics.
  • Participants completed anonymous self-report measures assessing intentions to use flunitrazepam, lifetime drug use, depression, self-esteem, and drug resistance self-efficacy.

Related Experiment Videos

Main Results:

  • Of 865 women, 5.3% were identified as potential future users of flunitrazepam.
  • Potential flunitrazepam use was significantly associated with limited drug resistance self-efficacy (AOR=9.3) and the presence of severe depressive symptoms and lowered self-esteem (AOR=3.2).

Conclusions:

  • Severe depressive symptoms and diminished self-esteem are significant risk factors for future flunitrazepam use in young women.
  • These findings suggest that individuals may use flunitrazepam to self-medicate psychological distress, highlighting the need for integrated mental health and substance use interventions.